MYCN is known to upregulate histone deacetylases (HDACs), including HDAC1/2/5 and sirtuin-1 (SIRT1), to promote gene repression and oncogenesis in both NB cell and mouse models [71,72,73]. The gene discussed is SIRT1; the disease is neuroblastoma.